Discovery and development of the Polo-like kinase inhibitor volasertib in cancer therapy | Leukemia
Polo-like kinases: structural variations lead to multiple functions | Nature Reviews Molecular Cell Biology
The Chromosomal Passenger Complex Activates Polo Kinase at Centromeres | PLOS Biology
Pharmaceuticals | Free Full-Text | Inhibition of Polo-like Kinase 1 by HMN-214 Blocks Cell Cycle Progression and Inhibits Neuroblastoma Growth
WAC Promotes Polo-like Kinase 1 Activation for Timely Mitotic Entry - ScienceDirect
Polo-like kinases: structural variations lead to multiple functions | Nature Reviews Molecular Cell Biology
Polo-like Kinase 1 Inhibitors in Human Cancer Therapy: Development and Therapeutic Potential | Journal of Medicinal Chemistry
Molecular and structural basis of polo-like kinase 1 substrate recognition: Implications in centrosomal localization | PNAS
Polo-like kinases and the orchestration of cell division | Nature Reviews Molecular Cell Biology
Polo-Like Kinase - an overview | ScienceDirect Topics
Polo-like kinases: conservation and divergence in their functions and regulation | Nature Reviews Molecular Cell Biology
Polo-like kinase inhibitors in hematologic malignancies - ScienceDirect
Structural Optimization and Anticancer Activity of Polo-like Kinase 1 (Plk1) Polo-Box Domain (PBD) Inhibitors and Their Prodrugs | ACS Pharmacology & Translational Science
Late mitotic failure in mice lacking Sak, a polo-like kinase: Current Biology
The polo-like kinase family. Schematic representation of the five... | Download Scientific Diagram
Polo-like kinases: structural variations lead to multiple functions | Nature Reviews Molecular Cell Biology
Genes | Free Full-Text | The Mitotic Cancer Target Polo-Like Kinase 1: Oncogene or Tumor Suppressor?
Polo-like kinase in trypanosomes: an odd member out of the Polo family | Open Biology
Frontiers | Polo-Like Kinase 4's Critical Role in Cancer Development and Strategies for Plk4-Targeted Therapy
Capturing Polo Kinase | Science
Mitotic Roles of Polo Like Kinase
Cells | Free Full-Text | The N-Terminal Region of the Polo Kinase Cdc5 Is Required for Downregulation of the Meiotic Recombination Checkpoint
The spindle assembly checkpoint and the spatial activation of Polo kinase determine the duration of cell division and prevent tumor formation | PLOS Genetics
Understanding the Polo Kinase machine | Oncogene
